CVRx Inc (CVRX) - Total Assets
Based on the latest financial reports, CVRx Inc (CVRX) holds total assets worth $92.28 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
CVRx Inc - Total Assets Trend (2019–2025)
This chart illustrates how CVRx Inc's total assets have evolved over time, based on quarterly financial data. Also see market cap of CVRx Inc for the company's overall valuation and market capitalisation.
CVRx Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
CVRx Inc's total assets of $92.28 Million consist of 97.0% current assets and 3.0% non-current assets. Review CVRX total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 72.2% |
| Accounts Receivable | $10.66 Million | 10.2% |
| Inventory | $12.21 Million | 11.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how CVRx Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See CVRX share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CVRx Inc's current assets represent 97.0% of total assets in 2025, a decrease from 99.3% in 2019.
- Cash Position: Cash and equivalents constituted 72.2% of total assets in 2025, down from 88.4% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 11.7% of total assets.
CVRx Inc Competitors by Total Assets
Key competitors of CVRx Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
SHE:300760
|
China | CN¥59.27 Billion |
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
Brainsway Ltd
NASDAQ:BWAY
|
USA | $121.97 Million |
|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
USA | $272.12 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩83.86 Billion |
CVRx Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.04 | 11.99 | 20.42 |
| Quick Ratio | 6.87 | 10.78 | 20.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $78.36 Million | $106.46 Million | $171.85 Million |
CVRx Inc - Advanced Valuation Insights
This section examines the relationship between CVRx Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.13 |
| Latest Market Cap to Assets Ratio | 0.64 |
| Asset Growth Rate (YoY) | -21.5% |
| Total Assets | $104.79 Million |
| Market Capitalization | $67.40 Million USD |
Valuation Analysis
Below Book Valuation: The market values CVRx Inc's assets below their book value (0.64x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: CVRx Inc's assets decreased by 21.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for CVRx Inc (2019–2025)
The table below shows the annual total assets of CVRx Inc from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $104.79 Million | -21.45% |
| 2024-12-31 | $133.41 Million | +15.78% |
| 2023-12-31 | $115.23 Million | -7.77% |
| 2022-12-31 | $124.94 Million | -18.10% |
| 2021-12-31 | $152.55 Million | +135.50% |
| 2020-12-31 | $64.78 Million | +122.55% |
| 2019-12-31 | $29.11 Million | -- |
About CVRx Inc
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased … Read more